Literature DB >> 28315855

Mechanisms and strategies of papillomavirus replication.

Alison A McBride1.   

Abstract

Animal and human papillomaviruses (HPVs) replicate persistently in specific types of stratified epithelia of their host. After the initial infection, the viral genome replicates at low levels in the dividing cells of the epithelium, and these cells form a reservoir of infection that can last for decades. When the infected cells differentiate, viral genomes replicate to high levels to form progeny virus that is released from the surface of the epithelium. This complex life cycle requires several different modes of viral DNA replication, but papillomaviruses are masters at hijacking key cellular processes to facilitate their own reproduction.

Entities:  

Keywords:  DNA damage response; DNA replication; HPV; human papillomavirus; partitioning; recombination dependent replication

Mesh:

Substances:

Year:  2017        PMID: 28315855     DOI: 10.1515/hsz-2017-0113

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  34 in total

1.  Uncovering the Role of the E1 Protein in Different Stages of Human Papillomavirus 18 Genome Replication.

Authors:  Alla Piirsoo; Martin Kala; Eve Sankovski; Mart Ustav; Marko Piirsoo
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

Review 2.  Hitchhiking of Viral Genomes on Cellular Chromosomes.

Authors:  Tami L Coursey; Alison A McBride
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

3.  Orf Virus-Based Therapeutic Vaccine for Treatment of Papillomavirus-Induced Tumors.

Authors:  M Schneider; M Müller; A Yigitliler; J Xi; C Simon; T Feger; H-J Rziha; F Stubenrauch; H-G Rammensee; T Iftner; R Amann
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

4.  A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.

Authors:  Joshua Hatterschide; Alexis C Brantly; Miranda Grace; Karl Munger; Elizabeth A White
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

5.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 6.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

7.  The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.

Authors:  Cindy Chiang; Eva-Katharina Pauli; Jennifer Biryukov; Katharina F Feister; Melissa Meng; Elizabeth A White; Karl Münger; Peter M Howley; Craig Meyers; Michaela U Gack
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

8.  Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.

Authors:  Justine Sitz; Sophie Anne Blanchet; Steven F Gameiro; Elise Biquand; Tia M Morgan; Maxime Galloy; Julien Dessapt; Elise G Lavoie; Andréanne Blondeau; Brandon C Smith; Joe S Mymryk; Cary A Moody; Amélie Fradet-Turcotte
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

9.  Cyclic AMP-Dependent Protein Kinase Exhibits Antagonistic Effects on the Replication Efficiency of Different Human Papillomavirus Types.

Authors:  Elina Lototskaja; Olga Sahharov; Marko Piirsoo; Martin Kala; Mart Ustav; Alla Piirsoo
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

10.  Group 1 innate lymphoid-cell-derived interferon-γ maintains anti-viral vigilance in the mucosal epithelium.

Authors:  John P Shannon; Sophia M Vrba; Glennys V Reynoso; Erica Wynne-Jones; Olena Kamenyeva; Courtney S Malo; Christian R Cherry; Daniel T McManus; Heather D Hickman
Journal:  Immunity       Date:  2021-01-11       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.